BDSI Biodelivery Sciences International Inc

Price (delayed)

$3

Market cap

$296.39M

P/E Ratio

9.68

Dividend/share

N/A

EPS

$0.31

Enterprise value

$254.39M

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and ...

Highlights
The price to earnings (P/E) is 29% lower than the last 4 quarters average of 13.6
BDSI's equity is up by 28% YoY and by 8% QoQ
Biodelivery Sciences International's net income has soared by 110% YoY but it has decreased by 8% from the previous quarter
BDSI's EPS has soared by 107% YoY but it is down by 6% QoQ
Biodelivery Sciences International's quick ratio has decreased by 24% from the previous quarter and by 24% YoY

Key stats

What are the main financial stats of BDSI
Market
Shares outstanding
98.8M
Market cap
$296.39M
Enterprise value
$254.39M
Valuations
Price to earnings (P/E)
9.68
Price to book (P/B)
2.41
Price to sales (P/S)
1.79
EV/EBIT
6.28
EV/EBITDA
5.34
EV/Sales
1.54
Earnings
Revenue
$165.72M
EBIT
$40.52M
EBITDA
$47.68M
Free cash flow
$37.88M
Per share
EPS
$0.31
Free cash flow per share
$0.38
Book value per share
$1.25
Revenue per share
$1.68
TBVPS
$1.92
Balance sheet
Total assets
$256.07M
Total liabilities
$133.3M
Debt
$58.72M
Equity
$122.78M
Working capital
$110.6M
Liquidity
Debt to equity
0.48
Current ratio
2.42
Quick ratio
2.04
Net debt/EBITDA
-0.88
Margins
EBITDA margin
28.8%
Gross margin
85.1%
Net margin
18.8%
Operating margin
24.5%
Efficiency
Return on assets
12.6%
Return on equity
27.5%
Return on invested capital
45.6%
Return on capital employed
22.7%
Return on sales
24.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BDSI stock price

How has the Biodelivery Sciences International stock price performed over time
Intraday
0%
1 week
-2.28%
1 month
15.38%
1 year
-30.23%
YTD
-3.23%
QTD
-3.23%

Financial performance

How have Biodelivery Sciences International's revenue and profit performed over time
Revenue
$165.72M
Gross profit
$140.95M
Operating income
$40.53M
Net income
$31.17M
Gross margin
85.1%
Net margin
18.8%
Biodelivery Sciences International's net income has soared by 110% YoY but it has decreased by 8% from the previous quarter
Biodelivery Sciences International's operating income has soared by 92% YoY but it has decreased by 5% from the previous quarter
Biodelivery Sciences International's net margin has surged by 84% YoY but it has decreased by 9% QoQ
Biodelivery Sciences International's operating margin has soared by 69% YoY but it has decreased by 6% from the previous quarter

Growth

What is Biodelivery Sciences International's growth rate over time

Valuation

What is Biodelivery Sciences International stock price valuation
P/E
9.68
P/B
2.41
P/S
1.79
EV/EBIT
6.28
EV/EBITDA
5.34
EV/Sales
1.54
BDSI's EPS has soared by 107% YoY but it is down by 6% QoQ
The price to earnings (P/E) is 29% lower than the last 4 quarters average of 13.6
The price to book (P/B) is 78% lower than the 5-year quarterly average of 11.1 and 29% lower than the last 4 quarters average of 3.4
BDSI's equity is up by 28% YoY and by 8% QoQ
BDSI's P/S is 46% below its 5-year quarterly average of 3.3 and 25% below its last 4 quarters average of 2.4
Biodelivery Sciences International's revenue has increased by 14% YoY

Efficiency

How efficient is Biodelivery Sciences International business performance
The company's return on assets has surged by 75% YoY but it fell by 11% QoQ
BDSI's ROS has soared by 68% YoY but it is down by 7% QoQ
The company's return on invested capital has surged by 66% YoY
BDSI's return on equity has surged by 52% year-on-year but it is down by 13% since the previous quarter

Dividends

What is BDSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BDSI.

Financial health

How did Biodelivery Sciences International financials performed over time
The total assets is 92% greater than the total liabilities
Biodelivery Sciences International's quick ratio has decreased by 24% from the previous quarter and by 24% YoY
The current ratio has contracted by 23% YoY and by 21% from the previous quarter
Biodelivery Sciences International's debt is 52% lower than its equity
The company's debt to equity fell by 41% YoY and by 30% QoQ
BDSI's equity is up by 28% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.